Advertisement
Research Article| Volume 16, ISSUE 3, P641-656, September 1996

Drug Susceptibility Testing

  • Leonid B. Heifets
    Correspondence
    Address reprint requests to: Leonid B. Heifets, MD, PhD, ScD, National Jewish Center for Immunology and Respiratory Medicine, 1400 Jackson Street, Denver, CO 80206
    Affiliations
    From the Mycobacteriology Laboratory, National Jewish Center for Immunology and Respiratory Medicine; and the Department of Microbiology, University of Colorado Health Sciences Center, Denver, Colorado
    Search for articles by this author
DOI:https://doi.org/10.1016/S0272-2712(18)30259-2
Drug Susceptibility Testing
Previous ArticlePolymerase Chain Reaction and other Amplification Techniques in Mycobacteriology
Next ArticleQuality Assurance in the Mycobacteriology Laboratory: Quality Control, Quality Improvement, and Proficiency Testing
      This paper is only available as a PDF. To read, Please Download here.
      An update on drug susceptibility testing is provided on methods for testing Mycobacteria tuberculosis, Mycobacteria avium, and rapidly growing mycobacteria. Emphasis is placed on the techniques that are currently available in clinical laboratories, and a critical overview is offered for some methods undergoing development.
      To read this article in full you will need to make a payment

      Purchase one-time access:

      Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online access
      One-time access price info
      • For academic or personal research use, select 'Academic and Personal'
      • For corporate R&D use, select 'Corporate R&D Professionals'

      Subscribers receive full online access to your subscription and archive of back issues up to and including 2002.

      Content published before 2002 is available via pay-per-view purchase only.

      Subscribe:

      Subscribe to Clinics in Laboratory Medicine
      Already a print subscriber? Claim online access
      Already an online subscriber? Sign in
      Register: Create an account
      Institutional Access: Sign in to ScienceDirect

      References

        • Agins B.D.
        • Berman D.S.
        • Spicehandler D.
        • et al.
        Effect of combined therapy with ansa-mycin, clofazimine, ethambutol and isoniazid for Mycobacterium avium infection in patients with AIDS.
        J Infect Dis. 1989; 159: 734-737
        • Benson C.A.
        • Kessler H.A.
        • Pottage Jr, JC
        • et al.
        Successful treatment of acquired immunodeficiency syndrome-related Mycobacterium avium complex disease with a multiple drug regimen including amikacin.
        Arch Intern Med. 1991; 151: 582-585
        • Berkovier H.
        Rifampin susceptibility tests for measuring membrane potential after 24h incubation.
        J Microbiol Methods. 1987; 7: 139-142
        • Canetti G.
        • Fox W.
        • Khomenko A.
        • et al.
        Advances in techniques of testing mycobacterial drug sensitivity and the use of sensitivity tests in tuberculosis control programs.
        Bull World Health Organ. 1969; 41: 21-43

      5. Chaisson RE, Benson C, Dube M, et al: Clarithromycin therapy for disseminated Mycobacterium avium complex (MAC) in AIDS patients [abstract]. Programs and Abstracts of the 32nd Interscience Conference Antimicrobial Agents Chemotherapy, Anaheim, 1992

        • Chaisson R.E.
        • Benson C.A.
        • Dube M.P.
        • et al.
        Clarithromycin therapy for M. avium complex bacteremia in patients with AIDS.
        Ann Intern Med. 1994; 121: 905-911
        • Chiu J.
        • Nussbaum J.
        • Bozzette S.
        • et al.
        Treatment of disseminated Mycobacterium avium complex infection with amikacin, ethambutol, rifampin, and ciprofloxacin.
        Ann Intern Med. 1990; 113: 358-361
        • Cynamon M.H.
        Comparative in vitro activities of MDL 473, rifampin, and ansamycin against Mycobacterium intracellulare.
        Antimicrob Agents Chemother. 1985; 28: 440
        • Cynamon M.H.
        • Palmer G.S.
        • Sorg T.B.
        Comparative in vitro activities of ampicillin, BMY28142, and imipinem against M. avium complex.
        Diagn Microbiol Infect. 1987; 6: 151
        • Dautzenberg B.
        • Saint Marc T.
        • Meyohas M.C.
        • et al.
        Clarithromycin and other antimyco-bacterial agents in the treatment of disseminated Mycobacterium avium infections in patients with acquired immunodeficiency syndrome.
        Arch Intern Med. 1993; 153: 368-373

      11. Dautzenberg B, St. Marc T, Averous V, et al: Clarithromycin containing regimens in the treatment of 54 AIDS patients with disseminated Mycobacterium avium-intracellulare infection. Presented at the 31st Interscience Conference on Antimicrobial Agents and Chemotherapy (ICAAC). Chicago, 1991

      12. Dautzenberg B, Truffot C, Legrand MF, et al: Relapses of M. avium infection in 23 HIV-positive and 8 HIV-negative patients receiving clarithromycin. Presented at the Frontiers in Mycobacteriology, Vail, CO, 1992

        • Dautzenberg B.
        • Truffot C.
        • Legris S.
        • et al.
        Activity of clarithromycin against Mycobacterium avium infection in patients with acquired immune deficiency syndrome.
        Am Rev Respir Dis. 1991; 144: 564-569
        • De Lalla F.
        • Maserati R.
        • Scarpellini P.
        Clarithromycin-ciprofloxacin-amikacin for therapy of Mycobacterium avium-Mycobacterium intracellulare bacteremia in patients with AIDS.
        Antimicrob Agents Chemother. 1992; 36: 1567-1569
        • Dickinson J.M.
        • Allen B.W.
        • Mitchison D.A.
        Slide culture sensitivity tests.
        Tubercle. 1989; 70: 115-121
        • Fenlon C.H.
        • Cynamon M.H.
        Comparative in vitro activities of ciprofloxacin and other 4-quinolones against Mycobacterium tuberculosis and Mycobacterium intracellulare.
        Antimicrob Agents Chemother. 1986; 29: 386-388
        • Hatfull G.R.
        • Jacobs W.R.
        Mycobacteriophages cornerstones of mycobacterial research.
        in: Bloom BR Tuberculosis: Pathogenesis, Protection and Control. ASM Press, Washington, DC1994

      18. Heifets L, Lindholm-Levy P, Libonati J, et al: Radiometric broth macrodilution method for determination of MIC with M. avium complex. Proposed Guidelines. Denver, CO, National Jewish Center for Immunology and Respiratory Medicine, 1993

        • Heifets L.
        • Mor N.
        • Vanderkolk J.
        M. avium strains resistant to clarithromycin and azithromycin.
        Antimicrob Agents Chemother. 1993; 37: 2364-2370
        • Heifets L.B.
        Dilemmas and realities in drug susceptibility testing of M. avium-M. intracellulare and other slowly growing nontuberculous mycobacteria.
        in: Heifets LB Drug Susceptibility in the Chemotherapy of Mycobacterial Infections. CRC Press, Boca Raton, FL1991
        • Heifets L.B.
        Drug susceptibility tests in the management of chemotherapy of tuberculosis.
        in: Heifets LB Drug Susceptibility in the Chemotherapy of Mycobacterial Infections. CRC Press, Boca Raton, FL1991
        • Heifets L.B.
        MIC as a quantitative measurement of the susceptibility of M. avium strains to seven antituberculosis drugs.
        Antimicrob Agents Chemother. 1988; 32: 1131-1136
        • Heifets L.B.
        • Good R.C.
        Current laboratory methods for the diagnosis of tuberculosis.
        in: Bloom BR Tuberculosis: Pathogenesis, Protection, and Control. ASM Press, Washington, DC1994
        • Heifets L.B.
        • Iseman M.D.
        Individualized therapy versus standard regimens in the treatment of M. avium infections.
        Am Rev Respir Dis. 1991; 144: 1-2
        • Heifets L.B.
        • Iseman M.D.
        • Lindholm-Levy P.J.
        Ethambutol MICs and MBCs for M. avium complex and M.
        tuberculosis. Antimicrob Agents Chemother. 1986; 30: 927-932
        • Heifets L.B.
        • Iseman M.D.
        • Lindholm-Levy P.J.
        • et al.
        Determination of ansamycin MICs for Mycobacterium avium complex in liquid medium by radiometric and conventional methods.
        Antimicrob Agents Chemother. 1985; 28: 570-575
        • Heifets L.B.
        • Lindholm-Levy P.J.
        Bacteriostatic and bactericidal activities of ciprofloxacin and ofloxacin against Mycobacterium tuberculosis and Mycobacterium avium complex.
        Tubercle. 1987; 68: 267-276
        • Heifets L.B.
        • Lindholm-Levy P.J.
        • Comstock R.D.
        Clarithromycin minimal inhibitory and bactericidal concentrations against M.
        avium. Am Rev Respir Dis. 1992; 145: 856-858
        • Heifets L.B.
        • Lindholm-Levy P.J.
        • Flory M.
        Comparison of bacteriostatic and bactericidal activity of isoniazid and ethionamide against M. avium and M.
        tuberculosis. Am Rev Respir Dis. 1991; 143: 268-270
        • Heifets L.B.
        • Lindholm-Levy P.J.
        • Flory M.
        Thiacetazone in vitro activity against M. avium and M.
        tuberculosis. Tubercle. 1990; 71: 287-291
        • Heifets L.B.
        • Lindholm-Levy P.J.
        • Flory M.A.
        Bactericidal activity in vitro of various rifamycins against M. avium and M.
        tuberculosis. Am Rev Respir Dis. 1990; 141: 626-630
        • Horsburgh Jr, CR
        • Mason U.G.
        • Heifets L.B.
        • et al.
        Response to therapy of pulmonary Mycobacterium avium-intracellulare infection correlates with results of in vitro susceptibility testing.
        Am Rev Respir Dis. 1987; 135: 418-421
        • Hoy J.
        • Mijch A.
        • Sandlum M.
        • et al.
        Quadruple-drug therapy for Mycobacterium avium-intracellulare bacteremia in AIDS patients.
        J Infect Dis. 1990; 161: 801-805
        • Isenberg H.D.
        Antimicrobial susceptibility testing: A critical review.
        J Antimicrob Chemother. 1988; 22: 73-75
        • Jacobs W.R.
        • Barletta R.G.
        • Udani R.
        • et al.
        Rapid assessment of drug susceptibility of M. tuberculosis by means of luciferase reporter phages.
        Science. 1993; 260: 819-822
        • Kemper C.A.
        • Meng T.C.
        • Nussbaum J.
        • et al.
        Treatment of Mycobacterium avium complex bacteremia in AIDS with a four-drug regimen: rifampin, ethambutol, clofazimine, and ciprofloxacin.
        Ann Intern Med. 1992; 116: 466-472
        • Korvick J.A.
        • Benson C.A.
        Advances in treatment and prophylaxis of M. avium complex in individuals infected with HIV.
        in: Korvick JA Benson CA Mycobacterium avium Complex Infection. Marcel Dekker, New York1996
        • Masur H.
        • Tuazon C.
        • Gill V.
        Effect of combined clofazimine and ansamycin therapy of Mycobacterium avium-Mycobacterium intracellulare bacteremia in patients with AIDS.
        J Infect Dis. 1987; 155: 127-129
        • National Committee for Clinical Laboratory Standards
        Performance standards for antimicrobial susceptibility testing.
        in: Jorgensen JH National Committee for Clinical Laboratory Standards. PA, Villanova1992

      40. National Committee for Laboratory Standards (ed): Methods for Dilution of Antimicrobial Susceptibility Tests for Bacteria that Grow Aerobically ed 4. NCCLS Document M7-A4. Villanova, PA, 1990

        • Nilsson L.E.
        • Hoffner S.E.
        • Ansehn S.
        Rapid susceptibility testing of M. tuberculosis by bioluminescence assay of mycobacteral ATP.
        Antimicrob Agents Chemother. 1988; 32: 1208-1212
        • Roberts G.
        • Goodman N.L.
        • Heifets L.
        • et al.
        Evaluation of the BACTEC radiometric method for recovery of mycobacteria and drug susceptibility testing of M. tuberculosis from acid-fast smear-positive specimens.
        J Clin Microbiol. 1983; 18: 689-696
        • Siddiqi S.M.
        • Heifets L.B.
        • Cynamon M.H.
        • et al.
        Rapid growth macrodilution method for determination of MICs for M. avium isolates.
        J Clin Microbiol. 1993; 31: 2332-2338
        • Stone M.S.
        • Wallace Jr, RJ
        • Swenson J.M.
        • et al.
        Agar disk elution method for susceptibility testing of Mycobacterium marinum and Mycobacterium fortuitum complex to sulfonamides and antibiotics.
        Antimicrob Agents Chemother. 1983; 24: 486-493
        • Swenson J.M.
        • Thornsberry C.
        • Silcox V.A.
        Rapidly growing mycobacteria: Testing of susceptibility to 34 antimicrobial agents by broth microdilution.
        Antimicrob Agents Chemother. 1982; 22: 186-192
        • Swenson J.M.
        • Wallace Jr, RJ
        • Silcox V.A.
        • et al.
        Antimicrobial susceptibility of five subgroups of M. fortuitum and M.
        chelonae. Antimicrob Agents Chemother. 1985; 28: 807-811
        • Telenti A.
        • Imboden P.
        • Marchesi F.
        Detection of rifampicin-resistance mutations in Mycobacterium tuberculosis.
        Lancet. 1993; 341: 647-650
        • Truffot-Pernot C.
        • Ji B.
        • Grosset J.
        Effect of pH on the in vitro potency of clarithromycin against Mycobacterium avium complex.
        Antimicrob Agents Chemother. 1991; 35: 1677-1678
        • Truffot-Pernot C.
        • Lounis N.
        • Grosset J.H.
        • et al.
        Clarithromycin is inactive against M.
        tuberculosis. Antimicrob Agents Chemother. 1995; 39: 2827-2828
        • Tsukamura M.
        Evidence that antituberculosis drugs are really effective in the treatment of pulmonary infections caused by Mycobacterium avium complex.
        Am Rev Respir Dis. 1988; 137: 144-148
        • Ulitzer S.
        • Kuhn J.
        Introduction of lux genes into bacteria: A new approach for specific determinants of bacteria and their antibiotic susceptibilities.
        in: Sclomerick J Andresen R Kapp A Bioluminescence and Chemiluminesce, New Perspectives. John Wiley & Sons, New York1987: 463-472
        • Wallace Jr, RJ
        • Dalovisio J.R.
        • Pankey G.A.
        Disk diffusion testing of susceptibility of Mycobacterium fortuitum and Mycobacterium chelonae to antibacterial agents.
        Antimicrob Agents Chemother. 1979; 16: 611-614
        • Wallace Jr, RJ
        • Nash D.R.
        • Steel L.C.
        • et al.
        Susceptibility testing of slowly growing mycobacteria in microdilution MIC method with 7H9 broth.
        Antimicrob Agents Chemother. 1986; 22: 186
        • Wallace Jr, RJ
        • Swenson J.M.
        • Silcox V.A.
        The rapidly growing mycobacteria: Characterization and susceptibility testing.
        Antimicrob Newsletter. 1985; 2: 85-87
        • Wallace Jr, RJ
        • Swenson J.M.
        • Silcox V.A.
        • et al.
        Disk diffusion testing with polymyxin and amikacin for differentiation of M. fortuitum and M.
        chelonae. J Clin Microbiol. 1982; 16: 1003-1006
        • Welch D.F.
        • Guruswamy A.P.
        • Sides S.J.
        • et al.
        Timely culture for mycobacteria which utilizes a microcolony method.
        J Clin Microbiol. 1993; 31: 2178-2184
        • Yajko D.M.
        • Nasos P.S.
        • Hadley W.K.
        Broth microdilution testing of susceptibilities to 30 antimicrobial agents of Mycobacterium avium strains from patients with acquired immunodeficiency syndrome.
        Antimicrob Agents Chemother. 1987; 31: 1579
        • Young L.S.
        • Wiviott L.
        • Wu M.
        • et al.
        Azithromycin for treatment of Mycobacterium avium-intracellulare complex infection in patients with AIDS.
        Lancet. 1991; 338: 1107-1109

      Article info

      Identification

      DOI: https://doi.org/10.1016/S0272-2712(18)30259-2

      Copyright

      © 1996 Elsevier Inc. Published by Elsevier Inc. All rights reserved.

      ScienceDirect

      Access this article on ScienceDirect

      The content on this site is intended for healthcare professionals.


      We use cookies to help provide and enhance our service and tailor content. To update your cookie settings, please visit the Cookie Preference Center for this site.
      Copyright © 2023 Elsevier Inc. except certain content provided by third parties.


      RELX